Skip to main content

Table 2 Primary outcomes in a study of the effect magnesium on patients with COVID-19

From: A randomized clinical trial investigating the impact of magnesium supplementation on clinical and biochemical measures in COVID-19 patients

Variable

Magnesium group

Placebo group

  

Value

 

Value

  

P

Oxygen therapy

Need oxygen therapy

9 (30%)

 

14(46.67)

  

< 0.001

No need for oxygen therapy

21 (70%)

16(53.33)

  
Back to article page

Virology Journal

ISSN: 1743-422X